# FDA recall D-0872-2022

> **Pfizer Inc.** · Class II · drug recall initiated 2022-04-22.

## Product

Accupril (Quinapril HCl Tablets) 10 mg,  90 Tablets Rx only NDC 0071-0530-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017

## Reason for recall

CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.

## Distribution

Nationwide and Puerto Rico

## Key facts

- **Recall number:** D-0872-2022
- **Recalling firm:** Pfizer Inc.
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2022-04-22
- **Report date:** 2022-05-25
- **Termination date:** 2023-10-05

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** New York, NY, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0872-2022

## Citation

> AI Analytics. FDA recall D-0872-2022. Retrieved 2026-06-02 from https://api.ai-analytics.org/recall/D-0872-2022. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*